Valuation : Mega Lifesciences

Market Cap 3.05TCr 92Cr 79Cr 74Cr 68Cr 127.58Cr 8.71TCr 128.27Cr 880.38Cr 342.66Cr 4.43TCr 344.58Cr 337.11Cr 15TCr P/E 2026 *
12.9x
P/E 2027 * 12.3x
Enterprise Value 2.59TCr 78Cr 67Cr 63Cr 58Cr 108.28Cr 7.39TCr 108.86Cr 747.18Cr 290.82Cr 3.76TCr 292.45Cr 286.11Cr 12TCr EV / Sales 2026 *
1.81x
EV / Sales 2027 * 1.65x
Free-Float
38.61%
Yield 2026 *
5.03%
Yield 2027 * 5.42%
1 day-2.78%
1 week-5.41%
Current month-2.78%
1 month-7.89%
3 months-2.78%
6 months-7.89%
Current year+4.48%
1 week 35
Extreme 35
36.5
1 month 35
Extreme 35
39.75
Current year 31.5
Extreme 31.5
40
1 year 27.75
Extreme 27.75
40
3 years 24.3
Extreme 24.3
46.75
5 years 24.3
Extreme 24.3
56.5
10 years 17.6
Extreme 17.6
56.5
Manager TitleAgeSince
Chief Executive Officer 64 01/01/1988
Director of Finance/CFO 62 01/01/1997
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 62 01/01/1998
Director/Board Member 64 01/01/2013
Director/Board Member 73 01/02/2013
Date Insider Type Main position Quantity % Market Cap. Importance
29/04/25 Buy

Chief Executive Officer

1,00,000 0.0115%
28/04/25 Buy

Chief Executive Officer

50,000 0.0057%
28/04/25 Buy

Chief Executive Officer

1,50,000 0.0172%
Change 5-day change 1-year change 3-year change Capi.($)
-2.78%-5.41%+25.00%-19.08% 92Cr
+0.28%-5.97%+58.34%+108.22% 1,03400Cr
+2.01%-0.71%+53.07%+68.99% 65TCr
+1.39%-2.18%+23.57%+75.43% 46TCr
+0.99%-4.81%+33.82%+36.08% 34TCr
-0.16%+2.39%+28.68%+46.27% 31TCr
-0.11%-2.64%+0.06%+11.42% 25TCr
+1.92%-0.93%+52.28%+70.67% 24TCr
+0.55%-3.10%-17.56%-54.91% 20TCr
+2.45%+0.77%+32.71%+95.59% 19TCr
Average +0.76%-2.80%+29.00%+43.87% 36.73TCr
Weighted average by Cap. +1.31%-3.31%+38.44%+66.57%

Financials

2026 *2027 *
Net sales 1.43TCr 43Cr 37Cr 35Cr 32Cr 60Cr 4.1TCr 60Cr 413.92Cr 161.11Cr 2.08TCr 162.01Cr 158.5Cr 6.91TCr 1.57TCr 47Cr 41Cr 38Cr 35Cr 65Cr 4.47TCr 66Cr 451.92Cr 175.9Cr 2.27TCr 176.88Cr 173.05Cr 7.54TCr
Net income 223.08Cr 6.71Cr 5.79Cr 5.44Cr 4.96Cr 9.33Cr 636.75Cr 9.38Cr 64Cr 25Cr 323.9Cr 25Cr 25Cr 1.07TCr 248.53Cr 7.47Cr 6.45Cr 6.07Cr 5.53Cr 10Cr 709.42Cr 10Cr 72Cr 28Cr 360.87Cr 28Cr 27Cr 1.2TCr
Net Debt -461.67Cr -14Cr -12Cr -11Cr -10Cr -19Cr -1.32TCr -19Cr -133.19Cr -52Cr -670.34Cr -52Cr -51Cr -2.22TCr -471.98Cr -14Cr -12Cr -12Cr -10Cr -20Cr -1.35TCr -20Cr -136.17Cr -53Cr -685.3Cr -53Cr -52Cr -2.27TCr
Logo Mega Lifesciences
Mega Lifesciences Public Company Limited is a Thailand-based company, which is engaged in health and wellness industry. Its segments include Brands, Distribution and OEM. MEGA We Care is its branded products business, through which it develops, manufactures, markets and sells its own range of nutraceuticals, complementary medicines, prescription pharmaceuticals and over the counter (OTC) health products. Maxxcare serves as its prominent distribution arm, specializing in the marketing, sales, and distribution of a range of branded prescription pharmaceuticals, OTC medications and fast-moving consumer goods (FMCG) across key markets such as Myanmar, Vietnam and Cambodia. Its suite of services encompasses warehouse management, collections and value-added initiatives, including tailored marketing services for principals in the pharmaceutical and FMCG sectors. Its manufacturing facilities in Thailand, Australia and Indonesia also accept production orders from various third-party customers.
Employees
-
Date Price Change Volume
01/26/01 THB 35.00 -2.78% 10,14,923
31/26/31 THB 36.00 -0.69% 6,68,601
28/26/28 THB 36.25 +0.69% 5,10,707
27/26/27 THB 36.00 +0.70% 4,73,482
26/26/26 THB 35.75 -3.38% 13,55,674
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
35.00THB
Average target price
42.71THB
Spread / Average Target
+22.04%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEGA Stock